These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29949146)

  • 1. HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway.
    Guan Q; Zhang Q; Zhang C; Liu Q; Ren QL
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3727-3733. PubMed ID: 29949146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTTIP participates in mammary cancer by promoting cell proliferation via PI3K/AKT pathway.
    Gao W; Wu XL; Li DZ; Liu HD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4181-4187. PubMed ID: 30024606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
    Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
    Guo X; Liu Y; Zheng X; Han Y; Cheng J
    Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
    Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
    J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
    Zhu L; Wang X; Wang T; Zhu W; Zhou X
    Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
    Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA LINC01224 promotes cell proliferation and inhibits apoptosis by regulating AKT3 expression via targeting miR‑485‑5p in endometrial carcinoma.
    Zuo X; Li W; Yan X; Ma T; Ren Y; Hua M; Yang H; Wu H; Zhu H
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
    Lei Y; Wang YH; Wang XF; Bai J
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
    Wang L; Zhao S; Mingxin YU
    Pharmazie; 2019 May; 74(5):295-300. PubMed ID: 31109400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
    Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L
    J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.
    Yun WK; Hu YM; Zhao CB; Yu DY; Tang JB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2786-2793. PubMed ID: 31002129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.